About PathGen
PathGen is a company based in Bogor (Indonesia) founded in 2020 by Susanti Susanti and Michael Rampangilei. PathGen offers products and services including Molecular Diagnostics Products, Research and Development Services, and Capacity Building Services. PathGen operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter Bogor, Indonesia
- Founders Susanti Susanti, Michael Rampangilei
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pt. Pathgen Diagnostik Teknologi
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PathGen
PathGen offers a comprehensive portfolio of products and services, including Molecular Diagnostics Products, Research and Development Services, and Capacity Building Services.
Tools for low-cost detection of cancer and diseases in clinical use
Advancing technologies for molecular diagnostics and healthcare innovations
Programs to enhance skills in diagnostic implementation and research
Funding Insights of PathGen
Investors in PathGen
PathGen has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include East Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in Southeast Asian startups and publishing reports on technology and sustainability.
|
Locked | Locked | Locked |
Investor details for PathGen
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PathGen
Investment portfolio details for PathGen
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PathGen
Detailed financials for PathGen
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pathgen Comparisons
Peer comparison for PathGen
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PathGen
PathGen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
Detailed competitors of PathGen
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pathgen
Complete news archive for PathGen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PathGen
PathGen was founded in 2020 and raised its 1st funding round 4 years after it was founded.
PathGen is headquartered in Bogor, Indonesia. It is registered at Bogor, Jawa Barat, Indonesia.
Susanti Susanti is the current CEO of PathGen. They have also founded this company.
PathGen was founded in 2020 and is based in Bogor, Indonesia, where an AI-driven digital pathology platform is operated within the healthcare sector. PCR-based molecular diagnostics for cancers such as colorectal and lung are offered, alongside research and development efforts in cancer diagnostics. Faster diagnosis processes, biomarker analysis, and resource sharing are facilitated across clinical and educational environments.
PathGen's top competitors include Aignostics, Deciphex and Pictor Labs.
PathGen offers Molecular Diagnostics Products, Research and Development Services, and Capacity Building Services.
PathGen has 1 investor. Key investors include East Ventures.